Literature DB >> 20121615

The utility of C4d, C9, and troponin T immunohistochemistry in acute myocardial infarction.

Crystal P Jenkins1, Diana M Cardona, Jennifer N Bowers, Bahram R Oliai, Robert W Allan, Sigurd J Normann.   

Abstract

CONTEXT: Full activation and involvement of the complement pathway follows acute myocardial infarction. Complement fragment C4d is a stable, covalently bound marker of complement activation. Troponin T is specific for cardiomyocytes.
OBJECTIVES: To determine the specificity of C4d, C9, and troponin T immunoreactivity in necrotic myocytes and to establish whether they can be used to delineate acute myocardial infarction.
DESIGN: Twenty-six autopsy cases with a total of 54 myocardium areas of infarction were reviewed retrospectively. Immunohistochemistry for C4d, C9, and troponin T was used on paraffin sections of formalin-fixed tissue. Controls consisted of 5 cases without evidence of infarction, and histologically normal myocardium functioned as an internal control.
RESULTS: C4d and C9 antibodies reacted strongly and diffusely with necrotic myocytes in all samples of infarctions for up to 2 days (19 of 19; 100%). Adjacent histologically normal myocytes were nonreactive, resulting in a clear delineation between damaged and viable myocardium. Reactivity declined with increased duration and was absent in scars. Troponin T showed loss of staining in preinflammatory lesions (8 of 13; 62%); however, nonspecific patchy loss of staining was present in negative controls and in viable myocardium. Immunostains provided new diagnoses in 2 cases, including evidence of reinfarction and a newly diagnosed acute myocardial infarction.
CONCLUSIONS: C4d and C9 have comparable reactivity and specificity for necrotic myocytes. C4d and C9 staining of necrotic myocytes is apparent before the influx of inflammatory cells, demonstrating utility in early myocardial infarction. Patchy loss of Troponin T in some cases of histologically normal myocardium limited its usefulness as a sole marker of infarction.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20121615     DOI: 10.5858/134.2.256

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  4 in total

1.  Multiplex quantitative imaging of human myocardial infarction by mass spectrometry-immunohistochemistry.

Authors:  Aleksandra Aljakna; Estelle Lauer; Sébastien Lenglet; Silke Grabherr; Tony Fracasso; Marc Augsburger; Sara Sabatasso; Aurélien Thomas
Journal:  Int J Legal Med       Date:  2018-03-19       Impact factor: 2.686

Review 2.  Molecular tissue changes in early myocardial ischemia: from pathophysiology to the identification of new diagnostic markers.

Authors:  Aleksandra Aljakna; Tony Fracasso; Sara Sabatasso
Journal:  Int J Legal Med       Date:  2018-01-23       Impact factor: 2.686

3.  Complement C3c as a biomarker in heart failure.

Authors:  A Frey; G Ertl; C E Angermann; U Hofmann; S Störk; S Frantz
Journal:  Mediators Inflamm       Date:  2013-12-30       Impact factor: 4.711

4.  A theoretical timeline for myocardial infarction: immunohistochemical evaluation and western blot quantification for Interleukin-15 and Monocyte chemotactic protein-1 as very early markers.

Authors:  Emanuela Turillazzi; Marco Di Paolo; Margherita Neri; Irene Riezzo; Vittorio Fineschi
Journal:  J Transl Med       Date:  2014-07-02       Impact factor: 5.531

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.